Crouzon syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:207OMIM:123500Q75.1
Who is this for?
Show terms as
19Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Crouzon syndrome, also known as craniofacial dysostosis type I or Crouzon craniofacial dysostosis, is a genetic disorder characterized by the premature fusion of certain skull bones (craniosynostosis). This early fusion prevents the skull from growing normally and affects the shape of the head and face. It is one of the most common craniosynostosis syndromes and is caused by mutations in the FGFR2 (fibroblast growth factor receptor 2) gene on chromosome 10. Approximately 30–60% of cases arise from de novo (new) mutations, with the remainder inherited from an affected parent. The hallmark features of Crouzon syndrome involve the craniofacial skeleton. Premature fusion of the coronal and sometimes other cranial sutures leads to brachycephaly (short, broad skull) or other abnormal head shapes. Midface hypoplasia (underdevelopment of the middle portion of the face) results in shallow orbits with proptosis (bulging eyes), a beaked nose, and relative mandibular prognathism (prominent lower jaw). Patients frequently experience dental malocclusion and a high-arched or cleft palate. Ocular complications include exposure keratitis due to proptosis, strabismus, and occasionally optic nerve compression leading to vision loss. Conductive hearing loss occurs in a significant proportion of patients due to middle ear anomalies or external auditory canal atresia. Elevated intracranial pressure is a serious concern and can develop due to restricted skull growth, potentially causing headaches, papilledema, and cognitive impairment if untreated. Importantly, intelligence is typically normal in Crouzon syndrome, though developmental delays can occur if raised intracranial pressure is not managed. Treatment of Crouzon syndrome is primarily surgical and requires a multidisciplinary approach involving craniofacial surgeons, neurosurgeons, ophthalmologists, otolaryngologists, orthodontists, and speech therapists. Early cranial vault remodeling surgery may be necessary to relieve intracranial pressure and reshape the skull. Midface advancement procedures, such as Le Fort III osteotomy or distraction osteogenesis, are often performed during childhood or adolescence to correct midface hypoplasia, improve airway patency, and protect the eyes. Obstructive sleep apnea is common and may require intervention including adenotonsillectomy, CPAP, or tracheostomy in severe cases. Hearing aids or surgical correction may be needed for hearing loss. Long-term follow-up is essential, as multiple staged surgeries are typically required throughout growth and development.

Also known as:

Clinical phenotype terms— hover any for plain English:

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

2 events
Aug 2025A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Sameek Roychowdhury — PHASE2

TrialRECRUITING
Jan 2025A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors

Cogent Biosciences, Inc. — PHASE1, PHASE2

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Crouzon syndrome.

View clinical trials →

No actively recruiting trials found for Crouzon syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Crouzon syndrome community →

Specialists

19 foundView all specialists →
CM
Carrie L Heike, MD, MS
SEATTLE, WA
Specialist
PI on 1 active trial
MP
Matthew L Speltz, PhD
SEATTLE, WA
Specialist
PI on 1 active trial
BB
Barbara B Biesecker
CLARKS SUMMIT, PA
Specialist
PI on 16 active trials
YM
yasser el hadidi, mds
Specialist
PI on 1 active trial
MP
Mark Sun, PhD
COON RAPIDS, MN
Specialist
PI on 1 active trial
CD
Caroline ROORYCK THAMBO, Dr
Specialist
PI on 1 active trial
CM
Carrie Heike, MD, MS
SEATTLE, WA
Specialist
PI on 1 active trial
SP
Sameek Roychowdhury, MD, PhD
COLUMBUS, OH
Specialist
PI on 2 active trials
VP
Vassiliki Papadimitrakopoulou
HOUSTON, TX
Specialist
PI on 10 active trials1 Crouzon syndrome publication
DM
Daniela Y Tanikawa, MD
Specialist
PI on 1 active trial
SP
Sheikh Riazuddin, PhD
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Crouzon syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Crouzon syndromeForum →

No community posts yet. Be the first to share your experience with Crouzon syndrome.

Start the conversation →

Latest news about Crouzon syndrome

Disease timeline:

New recruiting trial: A Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene Positivity Who Progressed After Chemotherapy

A new clinical trial is recruiting patients for Crouzon syndrome

New recruiting trial: A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors

A new clinical trial is recruiting patients for Crouzon syndrome

New recruiting trial: A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

A new clinical trial is recruiting patients for Crouzon syndrome

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Crouzon syndrome

What is Crouzon syndrome?

Crouzon syndrome, also known as craniofacial dysostosis type I or Crouzon craniofacial dysostosis, is a genetic disorder characterized by the premature fusion of certain skull bones (craniosynostosis). This early fusion prevents the skull from growing normally and affects the shape of the head and face. It is one of the most common craniosynostosis syndromes and is caused by mutations in the FGFR2 (fibroblast growth factor receptor 2) gene on chromosome 10. Approximately 30–60% of cases arise from de novo (new) mutations, with the remainder inherited from an affected parent. The hallmark feat

How is Crouzon syndrome inherited?

Crouzon syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Crouzon syndrome typically begin?

Typical onset of Crouzon syndrome is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Crouzon syndrome?

19 specialists and care centers treating Crouzon syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.